Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings.

HIV/AIDS : Research and Palliative Care
Janice LeeNathan Ford

Abstract

Integrase inhibitors represent an important new class of antiretroviral drugs. Elvitegravir, the second available integrase inhibitor to be submitted for regulatory approval appears to be a promising once-daily agent when combined with other antiretroviral drugs. Elvitegravir has demonstrated good efficacy and safety, with minimal side effects and no specific requirements in terms of laboratory monitoring. In addition, elvitegravir is available as a fixed-dose combination. However, the drug requires boosting and this leads to a number of drug-drug interactions and necessary dose adjustment when dosing with certain drugs, including dose reduction in the presence of atazanavir, lopinavir, rifabutin, and ketoconazole, and dose increase for ethinyl estradiol when co-administered with boosted elvitegravir. The main advantage of elvitegravir lies in its potential to be administered as a once-daily, single pill. Limitations include dose adjustment requirements, a relatively low genetic barrier to resistance, high price, and lack of data for use in children. Clinical trials addressing specific challenges encountered in resources-limited settings should be encouraged.

References

Aug 29, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Edwin DeJesusUNKNOWN 183-0101 Study Team
Aug 19, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Srinivasan RamanathanBrian P Kearney
Dec 28, 2007·Antimicrobial Agents and Chemotherapy·Edward P GarveyTamio Fujiwara
Jun 10, 2008·Expert Opinion on Emerging Drugs·Laith Q Al-MawsawiNouri Neamati
Sep 5, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Anita A MathiasBrian P Kearney
Sep 26, 2008·Clinical Pharmacology and Therapeutics·A A MathiasB P Kearney
Oct 24, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Srinivasan RamanathanBrian P Kearney
Nov 4, 2009·Antimicrobial Agents and Chemotherapy·Sherene MinStephen C Piscitelli
Aug 14, 2010·Viruses·Mathieu MétifiotYves Pommier
Nov 26, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mary-Ann DaviesUNKNOWN International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration
Apr 5, 2011·The Journal of Infectious Diseases·Jose-Luis BlancoRobert W Shafer
Nov 19, 2011·HIV/AIDS : Research and Palliative Care·Nathan FordAlexandra Calmy

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Investigational Drugs
Todd Wills, Vivian Vega
Expert Opinion on Pharmacotherapy
Rik Schrijvers, Zeger Debyser
Expert Review of Anti-infective Therapy
Harry W Lampiris
Current Opinion in HIV and AIDS
Jessica L AdamsAngela D M Kashuba
© 2022 Meta ULC. All rights reserved